ARSZX
Price
$10.97
Change
-$0.04 (-0.36%)
Updated
Jul 31 closing price
Net Assets
343.01M
DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
Interact to see
Advertisement

ARSZX vs DFSVX

ARSZX vs DFSVX Comparison Chart in %
View a ticker or compare two or three
VS
ARSZX vs. DFSVX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSZX is a Hold and DFSVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. ARSZX (343M). DFSVX pays higher dividends than ARSZX: DFSVX (1.50) vs ARSZX (0.48). ARSZX was incepted earlier than DFSVX: ARSZX (9 years) vs DFSVX (33 years). ARSZX (0.97) is less costly to investors than DFSVX (0.31). ARSZX is a more actively managed with annual turnover of: 36.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than ARSZX: DFSVX (0) vs ARSZX (5000000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. ARSZX (8.00). DFSVX return over 5 years is better than : 50.66 vs. ARSZX (11.59).
ARSZXDFSVXARSZX / DFSVX
Total Expense Ratio0.970.31313%
Annual Report Gross Expense Ratio0.970.31313%
Fund Existence9 years33 years-
Gain YTD10.14121.33648%
Front LoadN/AN/A-
Min. Initial Investment50000000-
Min. Initial Investment IRAN/AN/A-
Net Assets343M19.5B2%
Annual Yield % from dividends0.481.5032%
Returns for 1 year8.0034.3923%
Returns for 3 years17.1050.3734%
Returns for 5 years11.5950.6623%
Returns for 10 yearsN/A107.71-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I